Abrdn Healthcare Investors (NYSE:HQH – Get Free Report) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 145,100 shares, an increase of 115.0% from the January 15th total of 67,500 shares. Based on an average daily volume of 244,200 shares, the short-interest ratio is presently 0.6 days.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Truvestments Capital LLC bought a new position in Abrdn Healthcare Investors during the third quarter valued at approximately $46,000. International Assets Investment Management LLC purchased a new stake in Abrdn Healthcare Investors during the third quarter valued at approximately $682,000. Raymond James & Associates increased its holdings in Abrdn Healthcare Investors by 79.8% during the third quarter. Raymond James & Associates now owns 355,205 shares of the financial services provider’s stock valued at $6,614,000 after buying an additional 157,618 shares during the last quarter. Absolute Investment Advisers LLC purchased a new stake in Abrdn Healthcare Investors during the fourth quarter valued at approximately $1,786,000. Finally, Kingswood Wealth Advisors LLC increased its holdings in Abrdn Healthcare Investors by 63.7% during the fourth quarter. Kingswood Wealth Advisors LLC now owns 54,531 shares of the financial services provider’s stock valued at $875,000 after buying an additional 21,212 shares during the last quarter. Institutional investors own 32.60% of the company’s stock.
Abrdn Healthcare Investors Stock Performance
Shares of Abrdn Healthcare Investors stock opened at $17.95 on Friday. The company’s 50 day moving average is $17.08 and its 200 day moving average is $17.98. Abrdn Healthcare Investors has a twelve month low of $15.76 and a twelve month high of $19.79.
Abrdn Healthcare Investors Cuts Dividend
About Abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Read More
- Five stocks we like better than Abrdn Healthcare Investors
- What Are Dividend Challengers?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Where Do I Find 52-Week Highs and Lows?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.